Skip to main content

Breast Cancer Research and Treatment

Ausgabe 1/2020

Inhalt (25 Artikel)

Review

Psychoneurological symptom cluster in breast cancer: the role of inflammation and diet

Mridula A. George, Maryam B. Lustberg, Tonya S. Orchard

Preclinical study

Combined SOX10 GATA3 is most sensitive in detecting primary and metastatic breast cancers: a comparative study of breast markers in multiple tumors

Chaiwat Aphivatanasiri, Joshua Li, Ronald Chan, Shirley K. Jamidi, Julia Y. Tsang, Ivan K. Poon, Yan Shao, Joanna Tong, Ka-Fai To, Siu-Ki Chan, Fiona Tam, Sai-Yin Cheung, Ka-Ho Shea, Gary M. Tse

Open Access Clinical trial

Treatment effect of palbociclib plus endocrine therapy by prognostic and intrinsic subtype and biomarker analysis in patients with bone-only disease: a joint analysis of PALOMA-2 and PALOMA-3 clinical trials

Richard S. Finn, Massimo Cristofanilli, Johannes Ettl, Karen A. Gelmon, Marco Colleoni, Carla Giorgetti, Eric Gauthier, Yuan Liu, Dongrui R. Lu, Zhe Zhang, Cynthia Huang Bartlett, Dennis J. Slamon, Nicholas C. Turner, Hope S. Rugo

Open Access Clinical trial

Minimally invasive breast cancer excision using the breast lesion excision system under ultrasound guidance

W. B. G. Sanderink, L. J. A. Strobbe, P. Bult, M. S. Schlooz-Vries, S. Lardenoije, D. J. Venderink, I. Sechopoulos, N. Karssemeijer, W. Vreuls, R. M. Mann

Open Access Clinical trial

Influenza vaccination in breast cancer patients during subcutaneous trastuzumab in adjuvant setting

Therse Björkin Joona, Evangelos Digkas, Anna-Karin Wennstig, Karin Nyström, Andreas Nearchou, Cecilia Nilsson, Karlis Pauksens, Antonis Valachis

Clinical trial

Phase Ib clinical trial of the anti-frizzled antibody vantictumab (OMP-18R5) plus paclitaxel in patients with locally advanced or metastatic HER2-negative breast cancer

Jennifer R. Diamond, Carlos Becerra, Donald Richards, Alain Mita, Cynthia Osborne, Joyce O’Shaughnessy, Chun Zhang, Randall Henner, Ann M. Kapoun, Lu Xu, Bob Stagg, Shailaja Uttamsingh, Rainer K. Brachmann, Azeez Farooki, Monica Mita

Clinical trial

Adjuvant endocrine therapy is associated with improved overall survival in elderly hormone receptor-positive breast cancer patients

Jessica S. Crystal, Jamie Rand, Jeffrey Johnson, Sungjin Kim, Reva Basho, Farin Amersi, Armando E. Giuliano, Alice Chung

Clinical trial

Exercise training affects hemodynamics not cardiac function during anthracycline-based chemotherapy

Amy A. Kirkham, Sean A. Virani, Kelcey A. Bland, Donald C. McKenzie, Karen A. Gelmon, Darren E. R. Warburton, Kristin L. Campbell

Clinical trial

Impact of prior (neo)adjuvant trastuzumab (NAT) exposure on the efficacy of HER2-targeted therapy for metastatic breast cancer

Yada Kanjanapan, Sheau Wen Lok, Peter Gibbs, Richard De Boer, Belinda Yeo, Sally Greenberg, Frances Barnett, Louise Knott, Gary Richardson, Rachel Wong, Michelle Nottage, Ian M. Collins, Javier Torres, Janine Lombard, Julie Johns, Michael Harold, Laeeq Malik

Clinical trial

Shoulder amplitude movement does not influence postoperative wound complications after breast cancer surgery: a randomized clinical trial

Clarice Gomes Chagas Teodózio, Liz de Oliveira Marchito, Erica Alves Nogueira Fabro, Flávia Oliveira Macedo, Suzana Sales de Aguiar, Luiz Claudio Santos Thuler, Anke Bergmann

Open Access Clinical Trial

Influence of green tea consumption on endoxifen steady-state concentration in breast cancer patients treated with tamoxifen

C. Louwrens Braal, Koen G. A. M. Hussaarts, Lieke Seuren, Esther Oomen-de Hoop, Peter de Bruijn, Stefan A. J. Buck, Monique E. M. M. Bos, Martine F. Thijs-Visser, Hanneke J. M. Zuetenhorst, Daniëlle Mathijssen-van Stein, Mijntje B. Vastbinder, Roelof W. F. van Leeuwen, Teun van Gelder, Stijn L. W. Koolen, Agnes Jager, Ron H. J. Mathijssen

Clinical trial

Should we be talking about guidelines with patients? A qualitative analysis in metastatic breast cancer

Olivia Hull, Soumya J. Niranjan, Audrey S. Wallace, Beverly R. Williams, Yasemin E. Turkman, Stacey A. Ingram, Courtney P. Williams, Tom Smith, Sara J. Knight, Smita Bhatia, Gabrielle B. Rocque

Clinical trial

Induction of PIK3CA alterations during neoadjuvant letrozole may improve outcome in postmenopausal breast cancer patients

Signe Korsgaard Skriver, Maj-Britt Jensen, Jens-Ole Eriksen, Lise Barlebo Ahlborn, Ann Soegaard Knoop, Maria Rossing, Bent Ejlertsen, Anne-Vibeke Laenkholm

Clinical trial

Impact of breast cancer subtype on clinical outcomes after Gamma Knife radiosurgery for brain metastases from breast cancer: a multi-institutional retrospective study (JLGK1702)

Kyoko Aoyagi, Yoshinori Higuchi, Shigeo Matsunaga, Toru Serizawa, Shoji Yomo, Hitoshi Aiyama, Osamu Nagano, Takeshi Kondoh, Hiroyuki Kenai, Takashi Shuto, Jun Kawagishi, Hidefumi Jokura, Sonomi Sato, Kiyoshi Nakazaki, Kotaro Nakaya, Toshinori Hasegawa, Mariko Kawashima, Hideya Kawai, Kazuhiro Yamanaka, Yasushi Nagatomo, Masaaki Yamamoto, Yasunori Sato, Tomoyoshi Aoyagi, Tomoo Matsutani, Yasuo Iwadate

Open Access Clinical trial

Real-world survival outcomes of heavily pretreated patients with refractory HR+, HER2−metastatic breast cancer receiving single-agent chemotherapy—a comparison with MONARCH 1

Hope S. Rugo, Veronique Dieras, Javier Cortes, Debra Patt, Hans Wildiers, Joyce O’Shaughnessy, Esther Zamora, Denise A. Yardley, Gebra Cuyun Carter, Kristin M. Sheffield, Li Li, Valerie A. M. Andre, Xiaohong I. Li, Martin Frenzel, Yu-Jing Huang, Maura N. Dickler, Sara M. Tolaney

Open Access Clinical trial

Outcomes following lymphaticovenous anastomosis (LVA) for 100 cases of lymphedema: results over 24-months follow-up

Shan S. Qiu, Tim Pruimboom, Anouk J. M. Cornelissen, Rutger M. Schols, Sander M. J. van Kuijk, René R. W. J. van der Hulst

Clinical trial

Ultrasound visibility of select breast biopsy markers for targeted axillary node localization following neoadjuvant treatment: simulation using animal tissue models

Leah H. Portnow, Ellie Kwak, Gunjan M. Senapati, Dylan C. Kwait, Christine M. Denison, Catherine S. Giess

Epidemiology

Use of neoadjuvant versus adjuvant chemotherapy for hormone receptor-positive breast cancer: a National Cancer Database (NCDB) study

Michael Zeidman, J. Jaime Alberty-Oller, Meng Ru, Kereeti V. Pisapati, Erin Moshier, Soojin Ahn, Madhu Mazumdar, Elisa Port, Hank Schmidt

Epidemiology

The impact of selected risk factors among breast cancer molecular subtypes: a case-only study

Margherita Pizzato, Greta Carioli, Stefano Rosso, Roberto Zanetti, Carlo La Vecchia

Open Access Epidemiology

Previously diagnosed multiple primary malignancies in patients with breast carcinoma in Western Sweden between 2007 and 2018

Jenny Nyqvist, Toshima Z. Parris, Khalil Helou, Elisabeth Kenne Sarenmalm, Zakaria Einbeigi, Per Karlsson, Salmir Nasic, Anikó Kovács

Epidemiology

Frequency and spectrum of founder and non-founder BRCA1 and BRCA2 mutations in a large series of Russian breast cancer and ovarian cancer patients

Anna P. Sokolenko, Tatiana N. Sokolova, Valeria I. Ni, Elena V. Preobrazhenskaya, Aglaya G. Iyevleva, Svetlana N. Aleksakhina, Alexandr A. Romanko, Alexandr A. Bessonov, Tatiana V. Gorodnova, Elena I. Anisimova, Elena L. Savonevich, Ilya V. Bizin, Ilya A. Stepanov, Petr V. Krivorotko, Igor V. Berlev, Alexey M. Belyaev, Alexandr V. Togo, Evgeny N. Imyanitov

Epidemiology

Effect of functional variant rs11466313 on breast cancer susceptibility and TGFB1 promoter activity

Yan-Ting Zhou, Li-Yuan Zheng, Ya-Jun Wang, Li Yang, Yun-Tao Xie, Ipsita Panda, Xin-Xia Tian, Wei-Gang Fang

Zur Zeit gratis COVID-19 Brief Report

Patient-reported treatment delays in breast cancer care during the COVID-19 pandemic

Elizabeth Lerner Papautsky, Tamara Hamlish

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.